No, the NeuroStar Advanced Therapy TMS system is the first TMS device to be cleared by the U.S. Food and Drug Administration (FDA) for the treatment of major depression.
TheNeuroStar Advanced Therapy TMS system is also the first TMS device to have been evaluated in a large, multicenter, controlled clinical trial, as well as the only TMS system with the durability of its effects over 12 months established.